Section 21-28-3.28. – Security requirements generally.
§ 21-28-3.28. Security requirements generally. Security requirements for controlled substances shall be the same as those enumerated in federal law; provided, that the director of health may promulgate additional rules and regulations as required to prevent diversion of controlled substances. History of Section.P.L. 1974, ch. 183, § 2.
Section 21-28-3.29. – Repealed.
§ 21-28-3.29. Repealed.
Section 21-28-3.30. – Persons exempt from restrictions on possession of controlled substances.
§ 21-28-3.30. Persons exempt from restrictions on possession of controlled substances. The provisions of this chapter restricting the possession and having control of controlled substances shall not apply to: (1) Common carriers or to warehouse operators while engaged in lawfully transporting or storing controlled substances, or to any employee of them acting within the scope […]
Section 21-28-3.31. – Use of imitation controlled substance in research — Immunity.
§ 21-28-3.31. Use of imitation controlled substance in research — Immunity. No civil or criminal liability shall be imposed by virtue of this chapter on any practitioner, apothecary, or other person registered under this chapter who manufactures, distributes, or possesses an imitation controlled substance for use as a placebo by a registered practitioner in the […]
Section 21-28-3.32. – Electronic prescription database. [Effective until January 1, 2023.]
§ 21-28-3.32. Electronic prescription database. [Effective until January 1, 2023.] (a) The information contained in any prescription-drug-monitoring database maintained by the department of health pursuant to § 21-28-3.18 shall be disclosed only: (1) To a practitioner who certifies that the requested information is for the purpose of evaluating the need for, or providing medical treatment […]
Section 21-28-3.33. – Voluntary non-opiate directive form.
§ 21-28-3.33. Voluntary non-opiate directive form. (a) The department shall establish a voluntary non-opiate directive form. The form shall indicate to all practitioners that an individual shall not be administered or offered a prescription or medication order for an opiate. The form shall be posted on the department’s searchable website. An individual may execute and […]
Section 21-28-4.01. – Prohibited acts A — Penalties. [As amended by P.L. 2021, ch. 100, § 1 and P.L. 2021, ch. 101, § 1.]
§ 21-28-4.01. Prohibited acts A — Penalties. [As amended by P.L. 2021, ch. 100, § 1 and P.L. 2021, ch. 101, § 1.] (a)(1) Except as authorized by this chapter, it shall be unlawful for any person to manufacture, deliver, or possess with intent to manufacture or deliver a controlled substance. (2) Any person who […]
Section 21-28-4.01.1. – Certain quantities of controlled substances.
§ 21-28-4.01.1. Certain quantities of controlled substances. (a) Except as authorized by this chapter, it shall be unlawful for any person to manufacture, sell, or possess with intent to manufacture or sell, a controlled substance classified in schedule I or II (excluding marijuana) or to possess or deliver the following enumerated quantities of certain controlled […]
Section 21-28-3.20.1. – Authority of practitioner to prescribe, administer, and dispense — Cancer, palliative care and chronic intractable pain.
§ 21-28-3.20.1. Authority of practitioner to prescribe, administer, and dispense — Cancer, palliative care and chronic intractable pain. (a) A practitioner, in good faith and in the course of his or her professional practice managing pain associated with a cancer diagnosis, palliative or nursing home care, intractable or chronic intractable pain as provided in § […]
Section 21-28-3.21. – Operation of treatment and rehabilitation programs for drug dependent persons.
§ 21-28-3.21. Operation of treatment and rehabilitation programs for drug dependent persons. The administering or dispensing directly, but not prescribing, of any controlled substance listed in any schedule to a drug dependent person for the purpose of continuing his or her dependence upon the drugs in the course of conducting an authorized clinical investigation in […]